Designing conditionally activated therapeutics that unleash a powerful attack on cancer cells Company led by experienced team with proven track record of developing novel medicines for the treatment of cancer CAMBRIDGE, Mass., Nov. 20, 2019 /PRNewswire/ -- Werewolf Therapeutics, an oncology